JPH06284896A - Production of polyphenol glycoside - Google Patents
Production of polyphenol glycosideInfo
- Publication number
- JPH06284896A JPH06284896A JP12310392A JP12310392A JPH06284896A JP H06284896 A JPH06284896 A JP H06284896A JP 12310392 A JP12310392 A JP 12310392A JP 12310392 A JP12310392 A JP 12310392A JP H06284896 A JPH06284896 A JP H06284896A
- Authority
- JP
- Japan
- Prior art keywords
- polyphenol
- acid
- enzyme
- glycoside
- amylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 27
- 229930182470 glycoside Natural products 0.000 title claims abstract description 19
- -1 polyphenol glycoside Chemical class 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 102000004190 Enzymes Human genes 0.000 claims abstract description 23
- 108090000790 Enzymes Proteins 0.000 claims abstract description 23
- 102000013142 Amylases Human genes 0.000 claims abstract description 13
- 108010065511 Amylases Proteins 0.000 claims abstract description 13
- 235000019418 amylase Nutrition 0.000 claims abstract description 13
- 239000004382 Amylase Substances 0.000 claims abstract description 12
- 239000000758 substrate Substances 0.000 claims abstract description 9
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 8
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 7
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims abstract description 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 230000000593 degrading effect Effects 0.000 claims abstract description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 8
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 claims description 6
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 claims description 6
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 6
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 6
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 5
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000005487 catechin Nutrition 0.000 claims description 4
- 229950001002 cianidanol Drugs 0.000 claims description 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 3
- 229920000945 Amylopectin Polymers 0.000 claims description 3
- 229920000856 Amylose Polymers 0.000 claims description 3
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- 229940074360 caffeic acid Drugs 0.000 claims description 3
- 235000004883 caffeic acid Nutrition 0.000 claims description 3
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 3
- 229940074391 gallic acid Drugs 0.000 claims description 3
- 235000004515 gallic acid Nutrition 0.000 claims description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 3
- 229960004705 kojic acid Drugs 0.000 claims description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 3
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 claims description 3
- 229960001553 phloroglucinol Drugs 0.000 claims description 3
- 241000228245 Aspergillus niger Species 0.000 claims description 2
- 241000235527 Rhizopus Species 0.000 claims description 2
- 241000194049 Streptococcus equinus Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 241000187391 Streptomyces hygroscopicus Species 0.000 claims description 2
- 229960004337 hydroquinone Drugs 0.000 claims description 2
- IBHWREHFNDMRPR-UHFFFAOYSA-N phloroglucinol carboxylic acid Natural products OC(=O)C1=C(O)C=C(O)C=C1O IBHWREHFNDMRPR-UHFFFAOYSA-N 0.000 claims description 2
- 125000004403 catechin group Chemical group 0.000 claims 1
- 238000013329 compounding Methods 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000008351 acetate buffer Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 229940033495 antimalarials Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
(57)【要約】
【目的】 医薬や化粧品等の中間体や配合成分等として
有用なポリフェノール配糖体の酵素を用いる製造法を提
供する。
【構成】 サイクロデキストリン合成能を有さず、マル
トオリゴ糖分解能を有する糖化型アミラーゼの存在下に
おいて、糖基質とポリフェノール受容体を反応させるこ
とを特徴とするポリフェノール配糖体の製造法。(57) [Summary] [Objective] To provide a method for producing an enzyme of polyphenol glycoside, which is useful as an intermediate or a compounding ingredient of medicines and cosmetics. A method for producing a polyphenol glycoside, which comprises reacting a sugar substrate with a polyphenol receptor in the presence of a saccharified amylase having no cyclodextrin synthesizing ability and capable of degrading maltooligosaccharide.
Description
【0001】[0001]
【産業上の利用分野】この発明は、サイクロデキストリ
ン合成能を有さず、マルトオリゴ糖分解能を有する糖化
型アミラーゼを用いるポリフェノール配糖体の製造法に
関する。TECHNICAL FIELD The present invention relates to a method for producing a polyphenol glycoside using a saccharified amylase having no cyclodextrin synthesizing ability and malto-oligosaccharide degrading ability.
【0002】[0002]
【従来の技術】ポリフェノール配糖体は、従来から、甘
味料、鎮痛剤、下剤、抗マラリヤ剤および強壮剤等とし
て利用されるだけでなく、優れた美白効果を発揮する化
粧品の配合成分としても利用できる(特願平3−341
51号明細書参照)有用な化合物であり、本件出願人は
先に、サイクロデキストリン合成能とマルトース分解能
を有さない新規な酵素を用いるポリフェノール配糖体の
製造法を提供した(特願平4−27926号明細書参
照)。BACKGROUND OF THE INVENTION Polyphenol glycosides have hitherto been used not only as sweeteners, analgesics, laxatives, antimalarials and tonics, but also as a blending component of cosmetics which exhibit an excellent whitening effect. Available (Japanese Patent Application No. 3-341)
The present applicant has previously provided a method for producing a polyphenol glycoside using a novel enzyme that does not have cyclodextrin synthesizing ability and maltose decomposing ability (Japanese Patent Application No. Hei 4). -27926 specification).
【0003】この発明は、さらに別異の酵素を用いるポ
リフェノール配糖体の製造法を提供するためになされた
ものである。The present invention has been made to provide a method for producing a polyphenol glycoside using a different enzyme.
【0004】[0004]
【課題を解決するための手段】即ちこの発明は、従来は
工業的にほとんど利用されていなかった糖化型アミラー
ゼのなかで、サイクロデキストリン合成能を有さず、マ
ルトオリゴ糖分解能を有する酵素がポリフェノール配糖
体合成能を有するという知見に基づいてなされたもので
あって、その要旨は、サイクロデキストリン合成能を有
さず、マルトオリゴ糖分解能を有する糖化型アミラーゼ
の存在下において、糖基質とポリフェノール受容体を反
応させることを特徴とするポリフェノール配糖体の製造
法に存する。[Means for Solving the Problems] That is, according to the present invention, among saccharified amylases which have not been industrially used in the past, an enzyme having a cyclodextrin synthesizing ability and a maltooligosaccharide degrading ability is a polyphenol derivative. It was made based on the finding that it has a glycosynthetic ability, and the gist thereof is, in the presence of a glycosylated amylase that does not have a cyclodextrin synthetic ability and has a maltooligosaccharide degrading ability, a sugar substrate and a polyphenol receptor. In a method for producing a polyphenol glycoside.
【0005】本発明に使用する酵素、即ち、サイクロデ
キストリン合成能を有さず、マルトオリゴ糖分解能を有
する糖化型アミラーゼは自体公知の酵素であるが、該酵
素がポリフェノール配糖体合成能を有するということは
全く知られていなかった。この種の糖化型アミラーゼと
しては、例えば、バシルス・ズブチリス、ストレプトコ
ッカス・ボビス、ストレプトマイセス・ハイグロスコピ
カス、ストレプトマイセス・プレコックス、リゾプス・
デレマーおよびアスペルギルス・ニーガー等の細菌から
生産される上記特性を有する酵素が例示される。The enzyme used in the present invention, that is, the saccharified amylase having no cyclodextrin synthesizing ability and malto-oligosaccharide degrading ability is an enzyme known per se, but it is said that the enzyme has polyphenol glycoside synthesizing ability. That was not known at all. Examples of this type of saccharified amylase include Bacillus subtilis, Streptococcus bovis, Streptomyces hygroscopicus, Streptomyces plecox, and Rhizopus.
Examples are enzymes having the above-mentioned properties, which are produced from bacteria such as Dermer and Aspergillus niger.
【0006】上記の細菌を用いる該糖化型アミラーゼの
調製は自体公知の方法、例えば、福本らの方法[プロシ
ーディングズ・オブ・ジャパン・アカデミー(Proc. J
apanAcademy)、第27巻、第352頁〜第358頁(1
951年)およびアミラーゼシンポジウム(日本応用酵素
協会・アミラーゼ部会)、第47頁〜第53頁(1965
年)参照]等に準拠しておこなえばよい。The preparation of the saccharified amylase using the above-mentioned bacteria is known per se, for example, the method of Fukumoto et al. [Proceedings of Japan Academy (Proc. J.
apan Academy), 27, 352-358 (1)
951) and Amylase Symposium (Japan Applied Enzymes Association, Amylase Section), pp. 47-53 (1965).
Year))] etc.
【0007】上記の特性を有する糖化型アミラーゼは、
広範囲の糖基質を加水分解し、種々のポリフェノール類
にグルコースを転移させ、これによって多種多様なポリ
フェノール配糖体が得られる。この種の糖基質およびポ
リフェノール受容体としては下記のものが例示される:糖基質 :澱粉、アミロペクチン、アミロース、マルトオ
リゴ糖(G2〜G7)。ポリフェノール受容体 :カテキン、カフェー酸、コウジ
酸、ハイドロキノン、カテコール、レゾルシノール、プ
ロトカテキュー酸、α−レゾルシル酸、フロログルシノ
ール、没食子酸。Glycated amylase having the above characteristics is
It hydrolyzes a wide range of sugar substrates and transfers glucose to various polyphenols, resulting in a wide variety of polyphenol glycosides. The sugar substrate and polyphenols receptors of this kind are given below: sugar substrate: starches, amylopectin, amylose, maltooligosaccharides (G 2 ~G 7). Polyphenol receptors : catechin, caffeic acid, kojic acid, hydroquinone, catechol, resorcinol, protocatechuic acid, α-resorcylic acid, phloroglucinol, gallic acid.
【0008】澱粉等の糖基質およびカテキン等のポリフ
ェノール受容体を、上述の酵素の存在下で反応させる方
法は、通常、酢酸緩衝液等の緩衝液を用いて反応系のp
Hを約4〜9に調製し、約10〜60℃で約3〜70時
間おこなう。反応溶媒としては、水、メタノール/水
(5〜50体積%)、エタノール/水(5〜50体積%)、
酢酸エチル/水(10〜80体積%)等が例示される。な
お、使用する酵素を不溶性担体に固定化することによ
り、製造したポリフェノール配糖体から酵素を除くステ
ップを省略することもできる。The method of reacting a sugar substrate such as starch and a polyphenol acceptor such as catechin in the presence of the above-mentioned enzyme is usually a p-type reaction system using a buffer such as an acetate buffer.
H is adjusted to about 4 to 9 and is performed at about 10 to 60 ° C. for about 3 to 70 hours. Water, methanol / water as the reaction solvent
(5 to 50% by volume), ethanol / water (5 to 50% by volume),
Ethyl acetate / water (10 to 80% by volume) and the like are exemplified. The step of removing the enzyme from the produced polyphenol glycoside can be omitted by immobilizing the enzyme to be used on an insoluble carrier.
【0009】[0009]
【実施例】以下、本発明を実施例によって説明する。実施例1 酵素の調製は前記の福本らの方法に準拠しておこなっ
た。可溶性澱粉10w/v%、ポリペプトン2w/v
%、肉エキス2w/v%含有する水溶液を121℃で1
5分間加圧滅菌することによって培地を調製した。坂口
フラスコ(500ml)内へ該培地を100ml入れ、次
いでバシルス・ズブチリス1FO 14140を1白金
耳量植菌し、120rpmの条件下、30℃で24時間
振盪培養した(種培養)。上記のようにして新たに調製し
た培地3リットルに、該培養液を混入させ、該混合物を
ミニジャー(5リットル)内において、撹拌200rpm
および通気量3リットル/minの条件下において、3
7℃で120時間にわたって通気撹拌培養した(本培
養)。培養液2.5リットルを遠心分離処理(9000r
pm:15分間)に付すことによって得られた培養上清
2.45リットルに硫酸アンモニウムを加え、0.2〜
0.6飽和の画分を常法に従い得た。該画分を水に対し
て透析後、1M酢酸を用いてpHを5.0に調製し、5
0mM酢酸緩衝液(pH5.0)を用いて平衡化したデュ
オライトC−10カラム(15.9cm2×27cm)に
注入し、該酢酸緩衝液2リットルを用いて洗浄した。該
洗浄液を、分画分子量3000の限外濾過膜(旭化成工
業株式会社製ペンシル型モジュールSEP−0013)
を用いて150mlまで濃縮し、部分精製酵素を得た。
上述の精製過程の結果を表1にまとめて示す。EXAMPLES The present invention will be described below with reference to examples. Example 1 The enzyme was prepared according to the method of Fukumoto et al. Soluble starch 10 w / v%, polypeptone 2 w / v
%, An aqueous solution containing 2% w / v meat extract at 121 ° C.
The medium was prepared by autoclaving for 5 minutes. 100 ml of the medium was put into a Sakaguchi flask (500 ml), and then 1 platinum loop of Bacillus subtilis 1FO 14140 was inoculated, and the mixture was shake-cultured at 30 ° C. for 24 hours (seed culture). The culture solution was mixed with 3 liters of the medium newly prepared as described above, and the mixture was stirred in a mini jar (5 liters) at 200 rpm.
And under the condition of aeration rate of 3 liter / min, 3
The cells were cultured with aeration and stirring at 7 ° C. for 120 hours (main culture). Centrifuge 2.5 liters of culture solution (9000r
pm: 15 minutes), ammonium sulfate was added to 2.45 liters of the culture supernatant obtained by
A 0.6-saturated fraction was obtained according to a conventional method. The fraction was dialyzed against water and the pH was adjusted to 5.0 with 1M acetic acid.
It was injected into a Duolite C-10 column (15.9 cm 2 × 27 cm) equilibrated with 0 mM acetate buffer (pH 5.0), and the column was washed with 2 liters of the acetate buffer. An ultrafiltration membrane having a molecular weight cut off of 3000 (Pencil type module SEP-0013 manufactured by Asahi Kasei Kogyo Co., Ltd.)
Was concentrated to 150 ml to obtain a partially purified enzyme.
The results of the above purification process are summarized in Table 1.
【0010】[0010]
【表1】 [Table 1]
【0011】表1中の活性量(単位)は下記の方法によっ
て算出した値である。活性量 可溶性澱粉を50mM酢酸ナトリウム緩衝液(pH5.
3)に.0.5w/v%の濃度で溶解した溶液0.45
mlに酵素液0.05mlを加え、40℃で10分間反
応をおこなった後、0.5N塩酸1.0mlを添加する
ことによって反応を停止させ、次いで、ヨウ素5mgと
ヨウ化カリウム50mgを水100mlに溶解させた溶
液2.5mlを加え、室温で20分間放置後、660n
mにおける吸光度を測定し、該吸光度を1分間に1%低
下させる酵素量を1単位とした(ブランクテストは、酵
素の代わりに上記緩衝液を用いる以外は上記と同様の操
作によっておこなった)。The activity amount (unit) in Table 1 is a value calculated by the following method. An active amount of soluble starch was added to 50 mM sodium acetate buffer (pH 5.
3). 0.45 solution dissolved at a concentration of 0.5 w / v%
After adding 0.05 ml of enzyme solution to ml and reacting at 40 ° C. for 10 minutes, the reaction was stopped by adding 1.0 ml of 0.5N hydrochloric acid, and then 5 mg of iodine and 50 mg of potassium iodide were added to 100 ml of water. 2.5 ml of the solution dissolved in was added and left at room temperature for 20 minutes, then 660n
The absorbance at m was measured, and the amount of enzyme that reduced the absorbance by 1% per minute was defined as 1 unit (a blank test was performed by the same operation as above except that the buffer solution was used instead of the enzyme).
【0012】実施例2 (ポリフェノール配糖体合成活性測定法) ハイドロキノンの酢酸エチル溶液(0.5M)0.5ml
および可溶性澱粉5w/v%、酢酸ナトリウム緩衝液
(pH5.3)50mMおよび実施例1で製造した酵素1
0単位/mlを含有する水溶液0.5mlを蓋付試験管
(5ml)に入れ、該試験管を回転数280rpmの条件
下において、40℃で18時間振盪させた。静置後、水
性層を下記の条件下での薄層クロマトグラフィー分析に
付し、酵素のポリフェノール配糖体合成活性を確認し
た。 薄層 :メルク社製シリカゲル60F254ガラスプ
レート 展開溶媒:酢酸エチル/酢酸/水=3/2/2(体積比) 検出 :33v/v%硫酸/メタノール混合液を薄層
に噴霧後、該薄層を120℃で10分間加熱する。 Rf値 :0.61〜0.86(澱粉の分解物のRf値
は0.58以下である) Example 2 (Method for measuring polyphenol glycoside synthesis activity) 0.5 ml of a solution of hydroquinone in ethyl acetate (0.5 M)
And soluble starch 5 w / v%, sodium acetate buffer
(pH 5.3) 50 mM and enzyme 1 produced in Example 1
Test tube with a lid containing 0.5 ml of an aqueous solution containing 0 unit / ml
(5 ml), and the test tube was shaken at 40 ° C. for 18 hours under the condition of a rotation speed of 280 rpm. After standing, the aqueous layer was subjected to thin layer chromatography analysis under the following conditions to confirm the polyphenol glycoside synthesis activity of the enzyme. Thin layer: Silica gel 60F254 glass plate manufactured by Merck & Co., Inc. Developing solvent: ethyl acetate / acetic acid / water = 3/2/2 (volume ratio) Detection: 33 v / v% sulfuric acid / methanol mixed solution is sprayed on the thin layer, and then the thin layer Is heated at 120 ° C. for 10 minutes. Rf value: 0.61 to 0.86 (Rf value of the decomposed product of starch is 0.58 or less)
【0013】実施例3および4 澱粉の代わりに、アミロペクチン、アミロースまたはマ
ルトオリゴ糖を使用する以外は、実施例2の手順に準拠
して、本発明による酵素のポリフェノール配糖体合成活
性を確認した。 Examples 3 and 4 The polyphenol glycoside synthesizing activity of the enzyme of the present invention was confirmed according to the procedure of Example 2 except that amylopectin, amylose or maltooligosaccharide was used instead of starch.
【0014】実施例5〜13(受容体特異性) ハイドロキノンの代わりに、カテキン、カフェー酸、コ
ウジ酸、カテコール、レゾルシノール、プロトカテキュ
ー酸、α−レゾルシル酸、フロログルシノールまたは没
食子酸を使用する以外は、実施例2の手順に準拠して、
本発明による酵素のポリフェノール配糖体合成活性を確
認した。 Examples 5 to 13 (Receptor Specificity) Catechin, caffeic acid, kojic acid, catechol, resorcinol, protocatechuic acid, α-resorcylic acid, phloroglucinol or gallic acid is used instead of hydroquinone. Other than the above, according to the procedure of Example 2,
The activity of the enzyme according to the present invention to synthesize polyphenol glycoside was confirmed.
【0015】実施例14(ハイドロキノン配糖体の調製) 実施例1で調製した酵素液1,000単位、ハイドロキ
ノン2.5w/v%、澱粉2w/v%および酢酸緩衝液
(pH5.3)10mMから成る混合液100mlを三角
フラスコ(200ml)内に入れ、40℃で90時間反応
をおこなうことによってハイドロキノン配糖体を合成し
た。反応混合物にエタノール200mlを添加して反応
を停止させた後、析出不溶物を遠心分離処理によって除
去した。残留液をロータリーエバボレーターを用いる減
圧濃縮乾燥処理に付した後、残渣を水10mlに溶解さ
せ、該水溶液を下記の条件下でカラムクロマトグラフィ
ー処理に付し、溶離液体積440〜480mlで反応生
成物2を、同体積480〜540mlで反応生成物1を
溶離させた: カラム:内径2.6cm×長さ91cm 充填剤:バイオゲルp−2(400メッシュ) 溶離液:5%(v/v)エタノール水溶液 得られた画分を、それぞれロータリーエバボレーターを
用いて減圧濃縮乾固させた後、さらに真空乾燥機を用い
て乾燥処理をおこなって、白色粉末として生成物1を1
10mg、生成物2を51mg得た。該生成物は下記の
条件下での薄層クロマトグラフィーにおいて単一であっ
た。(生成物1のRf値:0.61、生成物2のRf
値:0.52): 薄層 :シリカゲル60F254 展開溶媒:酢酸エチル/酢酸/水(3:1:1) 検出 :紫外線照射また硝酸/メタノール(1:2)混
合物を噴霧後、110〜120℃に加熱して発色させ
る。1 H−NMR分析の結果、該生成物1および2をそれぞ
れハイドロキノン−O−α−D−グルコピラノシド、ハ
イドロキノン−O−α−マルトシドと同定した。 Example 14 (Preparation of hydroquinone glycoside) 1,000 units of enzyme solution prepared in Example 1, 2.5 w / v% hydroquinone, 2 w / v% starch and acetate buffer
A hydroquinone glycoside was synthesized by putting 100 ml of a mixed solution of 10 mM (pH 5.3) in an Erlenmeyer flask (200 ml) and performing a reaction at 40 ° C. for 90 hours. After 200 ml of ethanol was added to the reaction mixture to stop the reaction, the precipitated insoluble matter was removed by centrifugation. The residual liquid was subjected to vacuum concentration and drying treatment using a rotary evaporator, then the residue was dissolved in 10 ml of water, and the aqueous solution was subjected to column chromatography treatment under the following conditions to obtain a reaction product with an eluent volume of 440 to 480 ml. 2, the reaction product 1 was eluted with the same volume of 480 to 540 ml: column: inner diameter 2.6 cm x length 91 cm packing material: biogel p-2 (400 mesh) eluent: 5% (v / v) ethanol Aqueous solution The obtained fractions were concentrated to dryness under reduced pressure using a rotary evaporator, and then dried using a vacuum dryer to obtain product 1 as a white powder.
10 mg and 51 mg of the product 2 were obtained. The product was single in thin layer chromatography under the following conditions. (Rf value of product 1: 0.61, Rf of product 2
Value: 0.52): Thin layer: Silica gel 60F254 Developing solvent: Ethyl acetate / acetic acid / water (3: 1: 1) Detection: UV irradiation or 110-120 ° C after spraying nitric acid / methanol (1: 2) mixture Heat to develop color. As a result of 1 H-NMR analysis, the products 1 and 2 were identified as hydroquinone-O-α-D-glucopyranoside and hydroquinone-O-α-maltoside, respectively.
【0016】[0016]
【発明の効果】本発明によれば、従来は工業的にほとん
ど利用されていなかった特定の糖化型アミラーゼを利用
することによって、広範囲の糖基質とポリフェノール受
容体を原料として、特に医薬や化粧品等の配合成分とし
て有用な多種多様なポリフェノール配糖体を効率よく製
造することができる。INDUSTRIAL APPLICABILITY According to the present invention, a wide range of sugar substrates and polyphenol acceptors are used as raw materials by utilizing a specific saccharified amylase which has not been used industrially in the past. It is possible to efficiently produce a wide variety of polyphenol glycosides useful as a compounding ingredient of
───────────────────────────────────────────────────── フロントページの続き (72)発明者 西野 豊和 大阪府寝屋川市下木田町14番5号 倉敷紡 績株式会社技術研究所内 ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Toyokazu Nishino 14-5 Shimokita Town, Neyagawa City, Osaka Kurashiki Spinning Co., Ltd.
Claims (4)
マルトオリゴ糖分解能を有する糖化型アミラーゼの存在
下において、糖基質とポリフェノール受容体を反応させ
ることを特徴とするポリフェノール配糖体の製造法。1. No cyclodextrin synthesizing ability,
A method for producing a polyphenol glycoside, which comprises reacting a sugar substrate with a polyphenol acceptor in the presence of a saccharified amylase capable of degrading maltooligosaccharides.
リス、ストレプトコッカス・ボビス、ストレプトマイセ
ス・ハイグロスコピカス、ストレプトマイセス・プレコ
ックス、リゾプス・デレマーまたはアスペルギルス・ニ
ーガーが生産する酵素である請求項1記載の方法。2. The saccharified amylase is an enzyme produced by Bacillus subtilis, Streptococcus bovis, Streptomyces hygroscopicus, Streptomyces plecox, Rhizopus dermer or Aspergillus niger. the method of.
チンまたはマルトオリゴ糖(G2〜G7)である請求項1記
載の方法。3. The method according to claim 1, wherein the sugar substrate is starch, amylose, amylopectin or maltooligosaccharide (G 2 to G 7 ).
ェー酸、コウジ酸、ハイドロキノン、カテコール、レゾ
ルシノール、プロトカテキュー酸、α−レゾルシル酸、
フロログルシノールまたは没食子酸である請求項1記載
の方法。4. The polyphenol receptor is catechin, caffeic acid, kojic acid, hydroquinone, catechol, resorcinol, protocatechuic acid, α-resorcylic acid,
The method according to claim 1, which is phloroglucinol or gallic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12310392A JPH0736758B2 (en) | 1992-05-15 | 1992-05-15 | Method for producing polyphenol glycoside |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12310392A JPH0736758B2 (en) | 1992-05-15 | 1992-05-15 | Method for producing polyphenol glycoside |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06284896A true JPH06284896A (en) | 1994-10-11 |
| JPH0736758B2 JPH0736758B2 (en) | 1995-04-26 |
Family
ID=14852267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12310392A Expired - Fee Related JPH0736758B2 (en) | 1992-05-15 | 1992-05-15 | Method for producing polyphenol glycoside |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0736758B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06277087A (en) * | 1993-03-30 | 1994-10-04 | Ezaki Glico Co Ltd | Production of glycoside |
| WO2001073106A1 (en) * | 2000-03-28 | 2001-10-04 | Ezaki Glico Co., Ltd. | Process for producing glycosyl transfer product |
| WO2001091715A3 (en) * | 2000-06-02 | 2002-07-04 | Pentapharm Ltd | Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-d-glucopyranoside |
| WO2002072039A3 (en) * | 2001-03-09 | 2002-11-28 | Pentapharm Ltd | Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose |
| WO2003027049A1 (en) * | 2001-09-20 | 2003-04-03 | Ezaki Glico Co., Ltd. | Method of extracting and method of purifying an effective substance |
| CN104099387A (en) * | 2014-07-17 | 2014-10-15 | 浙江华康药业股份有限公司 | Saccharification technology for preparing starch sugar |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3037841U (en) * | 1996-08-13 | 1997-05-27 | 医療法人社団健心会 | Tooth cleaning tool |
-
1992
- 1992-05-15 JP JP12310392A patent/JPH0736758B2/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06277087A (en) * | 1993-03-30 | 1994-10-04 | Ezaki Glico Co Ltd | Production of glycoside |
| WO2001073106A1 (en) * | 2000-03-28 | 2001-10-04 | Ezaki Glico Co., Ltd. | Process for producing glycosyl transfer product |
| US7033800B2 (en) | 2000-03-28 | 2006-04-25 | Ezaki Glico Co., Ltd. | Glycosyl transfer product |
| KR100683236B1 (en) * | 2000-03-28 | 2007-02-15 | 에자끼구리고가부시키가이샤 | Method for preparing sugar transitions |
| WO2001091715A3 (en) * | 2000-06-02 | 2002-07-04 | Pentapharm Ltd | Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-d-glucopyranoside |
| WO2002072039A3 (en) * | 2001-03-09 | 2002-11-28 | Pentapharm Ltd | Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose |
| WO2003027049A1 (en) * | 2001-09-20 | 2003-04-03 | Ezaki Glico Co., Ltd. | Method of extracting and method of purifying an effective substance |
| US7282150B2 (en) | 2001-09-20 | 2007-10-16 | Ezaki Glico Co., Ltd. | Method of extracting and method of purifying an effective substance |
| CN104099387A (en) * | 2014-07-17 | 2014-10-15 | 浙江华康药业股份有限公司 | Saccharification technology for preparing starch sugar |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0736758B2 (en) | 1995-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5635611A (en) | Production of saccharide carboxylic acids | |
| JPS6192592A (en) | Production of branched cyclodextrin | |
| JPH0736758B2 (en) | Method for producing polyphenol glycoside | |
| FR2471387A1 (en) | PROCESS FOR THE PREPARATION OF MORANOLINE DERIVATIVES, NOVEL PRODUCTS THUS OBTAINED AND THEIR USE FOR CONTROLLING THE INCREASE IN SUGAR LEVELS IN BLOOD | |
| EP0608636A1 (en) | Cycloisomaltooligosaccharides, an enzyme and process for producing said oligosaccharides, and a process for producing said enzyme | |
| JP3457014B2 (en) | α-Glycosyl catecholamines, their production and use | |
| JPH0329241B2 (en) | ||
| US4910137A (en) | Twig branched cyclodextrin | |
| JP3365644B2 (en) | α-D-Glycosyl kasugamycin, process for producing the same, and antibacterial agent containing the same | |
| JP3024864B2 (en) | Ellagic acid glycoside and method for producing the same | |
| JP3012924B2 (en) | 2-methyl- {4-O- (2-amino-2-deoxy-β-glucopyranosyl) -1,2-dideoxy-α-glucopyrano} (2,1-d) -2-oxazoline and salts thereof | |
| JPH01213293A (en) | Production of flavonol glucoside readily soluble in water | |
| JP3075873B2 (en) | Novel cyclic isomaltooligosaccharide and method for producing the same | |
| JPH06284897A (en) | Production of beta-form polyphenol glycoside | |
| JP2664586B2 (en) | Enzymes capable of synthesizing polyphenol glycosides | |
| JP2805273B2 (en) | Glycoside production method | |
| JPH0776594A (en) | Process for producing sugar carboxylic acid and novel sugar carboxylic acid | |
| KR850000475B1 (en) | Method of preparing for the glycocyl moranoline derivative | |
| JPH0436679B2 (en) | ||
| JP3029925B2 (en) | Maltooligosaccharide derivatives and their production | |
| JP3916682B2 (en) | Method for producing glycoside | |
| MXPA04002280A (en) | Acetoacetylated saccharides and process of making the same. | |
| JP2888506B2 (en) | Non-reducing terminal azido maltooligosaccharide and method for producing the same | |
| KR100511419B1 (en) | beta-fructosyl-L-ascorbic acid and the preparation method thereof | |
| JPH044877B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |